Waheed Nadia
- SEC CIK
- 0002023884
In the past year, 3 open-market sale filings worth $220.9K and no purchases.
Current role at each company
- OCUL Ocular Therapeutix, IncChief Medical Officeras of Jun 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $220.9K
- 3 filings
- Net
- −$220.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Waheed Nadia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Waheed NadiaChief Medical Officer | SSale | −14.8K | $8.27 | −$122.6K | −4.7%300.1K after | 10b5-1 |
| Feb 24, 2026 (view filing) | Feb 20 | 4 days | Waheed NadiaChief Medical Officer | SSale | −3.51K | $7.74 | −$27.2K | −1.1%314.9K after | 10b5-1 |
| Feb 17, 2026 (view filing) | Feb 12 | 5 days | Waheed NadiaChief Medical Officer | SSale | −7.86K | $9.04 | −$71.1K | −2.4%318.4K after | 10b5-1 |
| Jun 3, 2025 (view filing) | Jun 2 | 1 day | Waheed NadiaChief Medical Officer | SSale | −13.9K | $8.05 | −$111.6K | −6.3%206.8K after | 10b5-1 |